avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf1
|
ENSMUSG00000054191.7 | Kruppel-like factor 1 (erythroid) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf1 | mm10_v2_chr8_+_84901928_84901992 | 0.91 | 1.9e-14 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_109849440 | 24.44 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr7_-_142578139 | 24.05 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr14_+_80000292 | 19.66 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr7_-_142656018 | 17.80 |
ENSMUST00000178921.1
|
Igf2
|
insulin-like growth factor 2 |
chr11_+_11684967 | 17.66 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr8_+_22974844 | 15.70 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr9_+_111019284 | 15.08 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr17_-_26201328 | 14.56 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr12_-_4841583 | 14.29 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr6_+_86078070 | 13.22 |
ENSMUST00000032069.5
|
Add2
|
adducin 2 (beta) |
chr14_-_70630149 | 12.26 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr11_+_58274799 | 12.06 |
ENSMUST00000108834.1
|
4930438A08Rik
|
RIKEN cDNA 4930438A08 gene |
chr8_+_123411424 | 11.84 |
ENSMUST00000071134.3
|
Tubb3
|
tubulin, beta 3 class III |
chr16_+_17646564 | 11.67 |
ENSMUST00000182117.1
ENSMUST00000182671.1 ENSMUST00000182344.1 |
Ccdc74a
|
coiled-coil domain containing 74A |
chr7_-_103813913 | 11.45 |
ENSMUST00000098192.3
|
Hbb-bt
|
hemoglobin, beta adult t chain |
chrX_-_7967817 | 10.97 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr16_+_17646464 | 10.86 |
ENSMUST00000056962.4
|
Ccdc74a
|
coiled-coil domain containing 74A |
chr11_+_74619594 | 10.86 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chr8_+_93810832 | 10.84 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr7_-_141016892 | 10.82 |
ENSMUST00000081924.3
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr11_-_102365111 | 10.64 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr12_+_109540979 | 10.58 |
ENSMUST00000129245.1
ENSMUST00000143836.1 ENSMUST00000124106.1 |
Meg3
|
maternally expressed 3 |
chrX_+_73639414 | 10.47 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr7_-_24760311 | 10.33 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr7_-_143460989 | 10.32 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr14_-_60086832 | 10.24 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr2_-_150668198 | 10.19 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr7_-_17062384 | 10.17 |
ENSMUST00000153833.1
ENSMUST00000108492.2 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr7_-_38107490 | 10.13 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr7_+_143005770 | 9.80 |
ENSMUST00000143512.1
|
Tspan32
|
tetraspanin 32 |
chr9_-_123678873 | 9.66 |
ENSMUST00000040960.6
|
Slc6a20a
|
solute carrier family 6 (neurotransmitter transporter), member 20A |
chr7_+_24370255 | 9.61 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr5_-_134915512 | 9.44 |
ENSMUST00000008987.4
|
Cldn13
|
claudin 13 |
chr11_+_32276400 | 9.39 |
ENSMUST00000020531.2
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr10_+_75948292 | 9.17 |
ENSMUST00000000926.2
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr7_+_142442330 | 9.16 |
ENSMUST00000149529.1
|
Tnni2
|
troponin I, skeletal, fast 2 |
chr17_-_26201363 | 9.09 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr2_+_163054682 | 9.08 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr17_-_6782775 | 8.97 |
ENSMUST00000064234.6
|
Ezr
|
ezrin |
chrX_-_7671341 | 8.94 |
ENSMUST00000033486.5
|
Plp2
|
proteolipid protein 2 |
chr7_+_25152456 | 8.73 |
ENSMUST00000098678.1
|
D930028M14Rik
|
RIKEN cDNA D930028M14 gene |
chr8_+_84723003 | 8.72 |
ENSMUST00000098571.4
|
G430095P16Rik
|
RIKEN cDNA G430095P16 gene |
chr17_-_35066170 | 8.65 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chrX_+_8271642 | 8.59 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr4_+_115057683 | 8.54 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_-_87875524 | 8.30 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr6_-_72958465 | 8.29 |
ENSMUST00000114050.1
|
Tmsb10
|
thymosin, beta 10 |
chr11_+_32276893 | 8.11 |
ENSMUST00000145569.1
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr7_-_142578093 | 8.09 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr15_+_89322969 | 8.09 |
ENSMUST00000066991.5
|
Adm2
|
adrenomedullin 2 |
chr6_+_86628174 | 8.06 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr6_+_72549652 | 8.02 |
ENSMUST00000134809.1
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr14_+_55765956 | 7.98 |
ENSMUST00000057569.3
|
Ltb4r1
|
leukotriene B4 receptor 1 |
chr11_-_116077562 | 7.93 |
ENSMUST00000174822.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr9_-_123678782 | 7.90 |
ENSMUST00000170591.1
ENSMUST00000171647.1 |
Slc6a20a
|
solute carrier family 6 (neurotransmitter transporter), member 20A |
chr8_-_71723308 | 7.88 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr4_-_117929726 | 7.87 |
ENSMUST00000070816.2
|
Artn
|
artemin |
chr14_-_60087347 | 7.82 |
ENSMUST00000149414.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr7_-_126704179 | 7.78 |
ENSMUST00000106364.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_+_75564086 | 7.76 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr17_-_25942821 | 7.75 |
ENSMUST00000148382.1
ENSMUST00000145745.1 |
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q |
chr17_-_48432723 | 7.69 |
ENSMUST00000046549.3
|
Apobec2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
chr7_+_143005638 | 7.66 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
Tspan32
|
tetraspanin 32 |
chr15_-_103252810 | 7.65 |
ENSMUST00000154510.1
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr6_+_72549430 | 7.64 |
ENSMUST00000155705.1
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr14_-_70627008 | 7.64 |
ENSMUST00000110984.2
|
Dmtn
|
dematin actin binding protein |
chr7_-_103843154 | 7.64 |
ENSMUST00000063957.4
|
Hbb-bh1
|
hemoglobin Z, beta-like embryonic chain |
chrX_-_150812932 | 7.47 |
ENSMUST00000131241.1
ENSMUST00000147152.1 ENSMUST00000143843.1 |
Maged2
|
melanoma antigen, family D, 2 |
chrX_-_74246364 | 7.44 |
ENSMUST00000130007.1
|
Flna
|
filamin, alpha |
chr17_+_48299952 | 7.42 |
ENSMUST00000170941.1
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr10_-_81500132 | 7.38 |
ENSMUST00000053646.5
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chrX_-_102251852 | 7.28 |
ENSMUST00000101336.3
ENSMUST00000136277.1 |
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr9_-_67832325 | 7.22 |
ENSMUST00000054500.5
|
C2cd4a
|
C2 calcium-dependent domain containing 4A |
chr8_-_105471481 | 7.21 |
ENSMUST00000014990.6
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr15_+_82341179 | 7.17 |
ENSMUST00000050349.2
|
Fam109b
|
family with sequence similarity 109, member B |
chr12_-_16999991 | 7.16 |
ENSMUST00000067572.6
|
Pqlc3
|
PQ loop repeat containing |
chr10_+_3973086 | 7.09 |
ENSMUST00000117291.1
ENSMUST00000120585.1 ENSMUST00000043735.7 |
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr2_-_131160006 | 6.98 |
ENSMUST00000103188.3
ENSMUST00000133602.1 ENSMUST00000028800.5 |
1700037H04Rik
|
RIKEN cDNA 1700037H04 gene |
chr10_-_80421847 | 6.97 |
ENSMUST00000156244.1
|
Tcf3
|
transcription factor 3 |
chr11_-_116077606 | 6.82 |
ENSMUST00000106450.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr8_+_123332676 | 6.78 |
ENSMUST00000010298.6
|
Spire2
|
spire homolog 2 (Drosophila) |
chr17_+_29114142 | 6.70 |
ENSMUST00000141797.1
ENSMUST00000132262.1 ENSMUST00000141239.1 ENSMUST00000138816.1 |
Gm16194
|
predicted gene 16194 |
chr16_-_18622403 | 6.67 |
ENSMUST00000167388.1
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr12_+_24831583 | 6.65 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr11_+_62077018 | 6.62 |
ENSMUST00000092415.5
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr3_+_108383829 | 6.55 |
ENSMUST00000090561.3
ENSMUST00000102629.1 ENSMUST00000128089.1 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr5_-_139325616 | 6.50 |
ENSMUST00000110865.1
|
Adap1
|
ArfGAP with dual PH domains 1 |
chr7_+_127091426 | 6.49 |
ENSMUST00000056288.5
|
AI467606
|
expressed sequence AI467606 |
chr7_-_126704522 | 6.44 |
ENSMUST00000135087.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr2_+_131186942 | 6.40 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr11_+_62575981 | 6.37 |
ENSMUST00000102643.1
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr2_+_131491958 | 6.37 |
ENSMUST00000110181.1
ENSMUST00000110180.1 |
Smox
|
spermine oxidase |
chr5_-_137741601 | 6.27 |
ENSMUST00000119498.1
ENSMUST00000061789.7 |
Nyap1
|
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
chr3_-_132950043 | 6.23 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chr4_-_152448808 | 6.19 |
ENSMUST00000159840.1
ENSMUST00000105648.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr7_-_135716374 | 6.18 |
ENSMUST00000033310.7
|
Mki67
|
antigen identified by monoclonal antibody Ki 67 |
chrX_-_102252154 | 6.17 |
ENSMUST00000050551.3
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr7_+_100495987 | 6.17 |
ENSMUST00000133044.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr6_+_72549252 | 6.15 |
ENSMUST00000114071.1
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr11_+_120948480 | 6.11 |
ENSMUST00000070653.6
|
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr5_+_76656512 | 6.10 |
ENSMUST00000086909.4
|
Gm10430
|
predicted gene 10430 |
chr7_+_143005677 | 6.10 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
Tspan32
|
tetraspanin 32 |
chr7_+_13278778 | 6.06 |
ENSMUST00000098814.4
ENSMUST00000146998.1 ENSMUST00000185145.1 |
Lig1
|
ligase I, DNA, ATP-dependent |
chr7_-_4752972 | 6.05 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr17_-_48146306 | 6.03 |
ENSMUST00000063481.7
|
9830107B12Rik
|
RIKEN cDNA 9830107B12 gene |
chr17_-_79355082 | 5.99 |
ENSMUST00000068958.7
|
Cdc42ep3
|
CDC42 effector protein (Rho GTPase binding) 3 |
chr1_-_119053619 | 5.98 |
ENSMUST00000062483.8
|
Gli2
|
GLI-Kruppel family member GLI2 |
chr4_-_98817537 | 5.98 |
ENSMUST00000102790.3
|
Kank4
|
KN motif and ankyrin repeat domains 4 |
chr11_-_116077954 | 5.95 |
ENSMUST00000106451.1
ENSMUST00000075036.2 |
Unc13d
|
unc-13 homolog D (C. elegans) |
chr7_-_80803253 | 5.91 |
ENSMUST00000167377.1
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr7_-_120982260 | 5.90 |
ENSMUST00000033169.8
|
Cdr2
|
cerebellar degeneration-related 2 |
chr17_+_40811089 | 5.87 |
ENSMUST00000024721.7
|
Rhag
|
Rhesus blood group-associated A glycoprotein |
chr10_+_75573448 | 5.81 |
ENSMUST00000006508.3
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr10_-_128401218 | 5.80 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr2_-_114052804 | 5.75 |
ENSMUST00000090269.6
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr17_+_35861318 | 5.73 |
ENSMUST00000074259.8
ENSMUST00000174873.1 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr9_+_65101453 | 5.71 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chr7_+_18884679 | 5.71 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr12_-_76709997 | 5.69 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chr11_-_116077927 | 5.68 |
ENSMUST00000156545.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr6_-_72958097 | 5.67 |
ENSMUST00000114049.1
|
Tmsb10
|
thymosin, beta 10 |
chr2_+_131491764 | 5.66 |
ENSMUST00000028806.5
ENSMUST00000110179.2 ENSMUST00000110189.2 ENSMUST00000110182.2 ENSMUST00000110183.2 ENSMUST00000110186.2 ENSMUST00000110188.1 |
Smox
|
spermine oxidase |
chr15_-_79285502 | 5.66 |
ENSMUST00000165408.1
|
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr6_+_39420378 | 5.65 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr2_+_30416031 | 5.61 |
ENSMUST00000042055.3
|
Ppp2r4
|
protein phosphatase 2A, regulatory subunit B (PR 53) |
chr17_+_56303321 | 5.57 |
ENSMUST00000001258.8
|
Uhrf1
|
ubiquitin-like, containing PHD and RING finger domains, 1 |
chr5_+_137288273 | 5.50 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr2_-_164779721 | 5.48 |
ENSMUST00000103095.4
|
Tnnc2
|
troponin C2, fast |
chr1_+_75382114 | 5.46 |
ENSMUST00000113590.1
ENSMUST00000148515.1 |
Speg
|
SPEG complex locus |
chr17_+_35861343 | 5.43 |
ENSMUST00000172931.1
|
Nrm
|
nurim (nuclear envelope membrane protein) |
chr2_+_25242929 | 5.39 |
ENSMUST00000114355.1
ENSMUST00000060818.1 |
Rnf208
|
ring finger protein 208 |
chr10_-_12964252 | 5.36 |
ENSMUST00000163425.1
ENSMUST00000042861.5 |
Stx11
|
syntaxin 11 |
chr9_+_69454066 | 5.36 |
ENSMUST00000134907.1
|
Anxa2
|
annexin A2 |
chr4_+_115057410 | 5.33 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr7_-_45211877 | 5.31 |
ENSMUST00000033057.7
|
Dkkl1
|
dickkopf-like 1 |
chr11_-_102082464 | 5.28 |
ENSMUST00000100398.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr8_-_122460666 | 5.27 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr2_-_156839790 | 5.23 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr8_-_53638945 | 5.18 |
ENSMUST00000047768.4
|
Neil3
|
nei like 3 (E. coli) |
chr7_-_103827922 | 5.14 |
ENSMUST00000023934.6
ENSMUST00000153218.1 |
Hbb-bs
|
hemoglobin, beta adult s chain |
chr12_-_17000108 | 5.12 |
ENSMUST00000054536.4
|
Pqlc3
|
PQ loop repeat containing |
chr4_-_43046196 | 5.08 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr7_+_43797567 | 5.07 |
ENSMUST00000085461.2
|
Klk8
|
kallikrein related-peptidase 8 |
chr9_-_21291124 | 5.07 |
ENSMUST00000086374.6
|
Cdkn2d
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr4_+_108579445 | 5.07 |
ENSMUST00000102744.3
|
Orc1
|
origin recognition complex, subunit 1 |
chr10_+_83722865 | 5.04 |
ENSMUST00000150459.1
|
1500009L16Rik
|
RIKEN cDNA 1500009L16 gene |
chr1_-_119053339 | 5.02 |
ENSMUST00000161301.1
ENSMUST00000161451.1 ENSMUST00000162607.1 |
Gli2
|
GLI-Kruppel family member GLI2 |
chr6_-_39420418 | 5.02 |
ENSMUST00000031985.6
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr15_+_78926720 | 4.95 |
ENSMUST00000089377.5
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr7_+_24777172 | 4.93 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr11_+_87755567 | 4.93 |
ENSMUST00000123700.1
|
A430104N18Rik
|
RIKEN cDNA A430104N18 gene |
chr6_-_39420281 | 4.93 |
ENSMUST00000114822.1
ENSMUST00000051671.4 |
Mkrn1
|
makorin, ring finger protein, 1 |
chr4_-_117929466 | 4.91 |
ENSMUST00000097913.2
|
Artn
|
artemin |
chr16_-_42340595 | 4.90 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr5_-_137741102 | 4.89 |
ENSMUST00000149512.1
|
Nyap1
|
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
chr2_-_29869785 | 4.88 |
ENSMUST00000047607.1
|
2600006K01Rik
|
RIKEN cDNA 2600006K01 gene |
chrX_+_161162744 | 4.88 |
ENSMUST00000074802.5
ENSMUST00000019101.4 ENSMUST00000112345.1 |
Scml2
|
sex comb on midleg-like 2 (Drosophila) |
chr17_-_56830916 | 4.88 |
ENSMUST00000002444.7
ENSMUST00000086801.5 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr1_-_193035651 | 4.85 |
ENSMUST00000016344.7
|
Syt14
|
synaptotagmin XIV |
chr6_+_122391379 | 4.81 |
ENSMUST00000043553.3
|
1700063H04Rik
|
RIKEN cDNA 1700063H04 gene |
chr9_+_69453620 | 4.80 |
ENSMUST00000034756.8
ENSMUST00000123470.1 |
Anxa2
|
annexin A2 |
chr19_-_4283033 | 4.76 |
ENSMUST00000167215.1
ENSMUST00000056888.6 |
Ankrd13d
|
ankyrin repeat domain 13 family, member D |
chr5_+_34949435 | 4.74 |
ENSMUST00000030984.7
|
Rgs12
|
regulator of G-protein signaling 12 |
chr7_+_29134971 | 4.74 |
ENSMUST00000160194.1
|
Rasgrp4
|
RAS guanyl releasing protein 4 |
chr17_+_25717171 | 4.73 |
ENSMUST00000172002.1
|
Gng13
|
guanine nucleotide binding protein (G protein), gamma 13 |
chr10_-_128400448 | 4.72 |
ENSMUST00000167859.1
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr5_-_107726017 | 4.71 |
ENSMUST00000159263.2
|
Gfi1
|
growth factor independent 1 |
chr13_-_49248146 | 4.71 |
ENSMUST00000119721.1
ENSMUST00000058196.6 |
Susd3
|
sushi domain containing 3 |
chr3_-_152166230 | 4.69 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr12_-_32061221 | 4.66 |
ENSMUST00000003079.5
ENSMUST00000036497.9 |
Prkar2b
|
protein kinase, cAMP dependent regulatory, type II beta |
chr4_-_154636831 | 4.65 |
ENSMUST00000030902.6
ENSMUST00000105637.1 ENSMUST00000070313.7 ENSMUST00000105636.1 ENSMUST00000105638.2 ENSMUST00000097759.2 ENSMUST00000124771.1 |
Prdm16
|
PR domain containing 16 |
chr5_+_34573744 | 4.64 |
ENSMUST00000147574.1
ENSMUST00000146295.1 |
Add1
|
adducin 1 (alpha) |
chr10_-_79788924 | 4.63 |
ENSMUST00000020573.6
|
Prss57
|
protease, serine 57 |
chr10_-_80577285 | 4.63 |
ENSMUST00000038558.8
|
Klf16
|
Kruppel-like factor 16 |
chr13_+_52583437 | 4.61 |
ENSMUST00000118756.1
|
Syk
|
spleen tyrosine kinase |
chr15_-_98778150 | 4.59 |
ENSMUST00000023732.5
|
Wnt10b
|
wingless related MMTV integration site 10b |
chr7_-_99238564 | 4.56 |
ENSMUST00000064231.7
|
Mogat2
|
monoacylglycerol O-acyltransferase 2 |
chr7_+_78914216 | 4.56 |
ENSMUST00000120331.2
|
Isg20
|
interferon-stimulated protein |
chr7_+_113513854 | 4.53 |
ENSMUST00000067929.8
ENSMUST00000129087.1 ENSMUST00000164745.1 ENSMUST00000136158.1 |
Far1
|
fatty acyl CoA reductase 1 |
chr5_+_34573664 | 4.53 |
ENSMUST00000114338.2
|
Add1
|
adducin 1 (alpha) |
chr14_+_32321987 | 4.52 |
ENSMUST00000022480.7
|
Ogdhl
|
oxoglutarate dehydrogenase-like |
chr17_-_48167187 | 4.50 |
ENSMUST00000053612.6
ENSMUST00000027764.8 |
A530064D06Rik
|
RIKEN cDNA A530064D06 gene |
chr9_+_56865104 | 4.49 |
ENSMUST00000035661.5
|
Cspg4
|
chondroitin sulfate proteoglycan 4 |
chr11_+_69964758 | 4.48 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr11_-_3504766 | 4.46 |
ENSMUST00000044507.5
|
Inpp5j
|
inositol polyphosphate 5-phosphatase J |
chr19_-_5273080 | 4.45 |
ENSMUST00000025786.7
|
Pacs1
|
phosphofurin acidic cluster sorting protein 1 |
chr16_-_22657182 | 4.44 |
ENSMUST00000023578.7
|
Dgkg
|
diacylglycerol kinase, gamma |
chr9_+_54699514 | 4.43 |
ENSMUST00000154690.1
|
Dnaja4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr5_-_67815852 | 4.42 |
ENSMUST00000141443.1
|
Atp8a1
|
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
chr7_-_100514800 | 4.41 |
ENSMUST00000054923.7
|
Dnajb13
|
DnaJ (Hsp40) related, subfamily B, member 13 |
chr2_-_181693810 | 4.39 |
ENSMUST00000108776.1
ENSMUST00000108771.1 ENSMUST00000108779.1 ENSMUST00000108769.1 ENSMUST00000108772.1 ENSMUST00000002532.2 |
Rgs19
|
regulator of G-protein signaling 19 |
chr6_-_39419967 | 4.34 |
ENSMUST00000122996.1
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr4_+_134315112 | 4.33 |
ENSMUST00000105875.1
ENSMUST00000030638.6 |
Trim63
|
tripartite motif-containing 63 |
chr11_-_17052344 | 4.31 |
ENSMUST00000020321.6
|
Plek
|
pleckstrin |
chrX_-_74246534 | 4.31 |
ENSMUST00000101454.2
ENSMUST00000033699.6 |
Flna
|
filamin, alpha |
chr9_+_119063429 | 4.31 |
ENSMUST00000141185.1
ENSMUST00000126251.1 ENSMUST00000136561.1 |
Vill
|
villin-like |
chr6_+_134929089 | 4.29 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr15_-_79285470 | 4.29 |
ENSMUST00000170955.1
|
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr15_+_80091320 | 4.28 |
ENSMUST00000009728.6
ENSMUST00000009727.5 |
Syngr1
|
synaptogyrin 1 |
chr19_+_8802486 | 4.27 |
ENSMUST00000172175.1
|
Zbtb3
|
zinc finger and BTB domain containing 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 19.9 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
5.9 | 17.7 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.6 | 13.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
4.4 | 17.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
4.3 | 8.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
4.3 | 12.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
3.9 | 11.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
3.7 | 11.0 | GO:0030221 | basophil differentiation(GO:0030221) |
3.3 | 13.3 | GO:1902896 | terminal web assembly(GO:1902896) |
3.0 | 29.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.0 | 11.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
2.9 | 26.4 | GO:0002432 | granuloma formation(GO:0002432) |
2.9 | 23.2 | GO:0015671 | oxygen transport(GO:0015671) |
2.8 | 22.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.8 | 8.3 | GO:0002215 | defense response to nematode(GO:0002215) |
2.7 | 11.0 | GO:0060032 | notochord regression(GO:0060032) |
2.7 | 13.4 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
2.6 | 7.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.5 | 15.1 | GO:1902732 | antifungal humoral response(GO:0019732) positive regulation of chondrocyte proliferation(GO:1902732) |
2.5 | 14.9 | GO:0032796 | uropod organization(GO:0032796) |
2.5 | 32.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.3 | 6.8 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
2.3 | 6.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.2 | 17.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.1 | 12.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
2.1 | 6.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.0 | 8.0 | GO:0042223 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) cellular response to molecule of fungal origin(GO:0071226) |
2.0 | 5.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.9 | 5.7 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.9 | 15.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.9 | 13.1 | GO:0051775 | response to redox state(GO:0051775) |
1.8 | 5.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
1.8 | 7.2 | GO:0015793 | glycerol transport(GO:0015793) |
1.8 | 48.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.7 | 6.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.7 | 13.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.7 | 10.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
1.6 | 6.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.5 | 1.5 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
1.5 | 4.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
1.5 | 10.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.5 | 7.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.5 | 5.9 | GO:0030070 | insulin processing(GO:0030070) |
1.5 | 4.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.5 | 24.9 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
1.4 | 2.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.4 | 11.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.4 | 4.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.4 | 5.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
1.4 | 10.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.3 | 6.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.3 | 3.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
1.3 | 1.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.3 | 2.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.3 | 3.8 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
1.2 | 4.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.2 | 2.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.2 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.2 | 4.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
1.2 | 7.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.2 | 3.6 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.2 | 9.5 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.1 | 4.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
1.1 | 3.3 | GO:1990523 | bone regeneration(GO:1990523) |
1.1 | 4.3 | GO:0010286 | heat acclimation(GO:0010286) |
1.1 | 5.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.0 | 2.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
1.0 | 2.0 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.0 | 3.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.0 | 8.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.0 | 3.0 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.0 | 3.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.0 | 3.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.0 | 3.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.0 | 11.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.0 | 11.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 2.9 | GO:0010936 | CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment(GO:0002362) negative regulation of macrophage cytokine production(GO:0010936) evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 5.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.0 | 5.8 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.9 | 2.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 4.7 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.9 | 12.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 2.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.9 | 2.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.9 | 4.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.9 | 4.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.9 | 3.6 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.9 | 13.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 3.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.9 | 3.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.9 | 0.9 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.9 | 6.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.9 | 3.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 6.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 8.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.8 | 2.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.8 | 13.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 4.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.8 | 2.5 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.8 | 2.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.8 | 7.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 12.0 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 1.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.8 | 1.6 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.8 | 2.4 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.8 | 3.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) response to dithiothreitol(GO:0072720) |
0.8 | 4.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.8 | 5.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.8 | 5.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.8 | 3.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 2.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.7 | 33.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.7 | 3.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.7 | 1.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.7 | 3.6 | GO:0035989 | tendon development(GO:0035989) |
0.7 | 2.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.7 | 2.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.7 | 1.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.7 | 2.1 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
0.7 | 2.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.7 | 2.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.7 | 2.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.7 | 2.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 2.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.7 | 2.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.7 | 4.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 2.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.7 | 2.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 6.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 2.7 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
0.7 | 2.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.7 | 2.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 5.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 3.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.7 | 5.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 2.6 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.6 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.6 | 3.9 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.6 | 2.6 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 7.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 2.5 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 6.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 8.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.6 | 0.6 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.6 | 1.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 6.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.6 | 1.8 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 6.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 3.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 4.3 | GO:0042148 | strand invasion(GO:0042148) |
0.6 | 2.4 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.6 | 3.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 5.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.6 | 5.9 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 1.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.6 | 1.8 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.6 | 2.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.6 | 3.5 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.6 | 1.2 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.6 | 0.6 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.6 | 2.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.6 | 2.8 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.6 | 1.7 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.6 | 11.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 1.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 3.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 11.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 1.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 2.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 4.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 5.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 2.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 3.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 8.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 6.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 1.0 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.5 | 1.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 6.0 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 5.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 2.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 1.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 1.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 2.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 8.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 4.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 2.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.5 | 1.4 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.5 | 2.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 2.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.5 | 1.4 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.5 | 2.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.5 | 1.4 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.5 | 1.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 1.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.4 | 6.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 1.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 1.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 1.8 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.4 | 2.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.4 | 3.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 7.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 2.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 2.6 | GO:0051790 | acetate metabolic process(GO:0006083) short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 9.7 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 2.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 4.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 2.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 2.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 2.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.4 | 2.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 8.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.2 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.4 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 3.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 2.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.4 | 1.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 2.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 0.8 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 1.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 10.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.4 | 1.1 | GO:2000556 | T-helper 1 cell cytokine production(GO:0035744) regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.4 | 3.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.4 | 2.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 2.3 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
0.4 | 2.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 13.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 2.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 1.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 4.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 9.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.7 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 2.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 0.4 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.4 | 1.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.4 | 1.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 3.5 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.4 | 1.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.3 | 1.0 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.3 | 1.0 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 1.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.0 | GO:0001805 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.3 | 1.4 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.3 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 2.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 7.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 0.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.3 | 2.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 2.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.3 | 3.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 3.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 1.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 2.3 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 3.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 5.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 1.6 | GO:0044805 | late nucleophagy(GO:0044805) |
0.3 | 2.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 3.6 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.3 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 1.3 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.3 | 0.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 4.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 4.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 5.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 | 0.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 27.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 8.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 2.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 2.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 2.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 4.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.3 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 13.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 0.9 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 0.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.6 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 2.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.3 | 5.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 13.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 5.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 8.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 1.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.9 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.3 | 1.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 3.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 1.1 | GO:0032079 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 3.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 2.2 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
0.3 | 1.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.3 | 0.8 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.3 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 0.8 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
0.3 | 1.6 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 1.0 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.3 | 3.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 1.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 4.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.3 | 2.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 1.0 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.3 | 0.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 3.6 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.3 | 0.8 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 0.8 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.3 | 2.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 1.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 5.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 2.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 8.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 8.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 3.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 6.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 1.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 1.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.2 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 1.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 2.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 8.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.2 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.7 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.2 | 1.3 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 1.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.2 | 1.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.6 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 1.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 4.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.8 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 1.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 1.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 1.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 2.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 12.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 5.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 6.4 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 3.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 3.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 5.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.2 | 1.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 1.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.7 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 3.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 2.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.4 | GO:0001743 | optic placode formation(GO:0001743) |
0.2 | 0.5 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 1.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.5 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 2.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 3.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 0.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.7 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.2 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 2.7 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 2.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.8 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 2.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 5.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.2 | 0.3 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.2 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 8.7 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 1.3 | GO:0033363 | secretory granule organization(GO:0033363) |
0.2 | 9.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.5 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 1.4 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 2.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.2 | 2.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.6 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.2 | 2.7 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 0.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 2.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 20.5 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 2.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 2.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 1.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 1.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 2.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.4 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.1 | 1.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 3.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 1.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 1.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 6.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 4.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 1.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.1 | 0.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 1.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.0 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 3.5 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.6 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.1 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 2.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 1.2 | GO:1990173 | regulation of establishment of protein localization to telomere(GO:0070203) protein localization to nuclear body(GO:1903405) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 2.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.3 | GO:0051866 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 3.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.1 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 1.8 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 3.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 2.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 1.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 1.5 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 1.7 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0060073 | micturition(GO:0060073) synaptic transmission involved in micturition(GO:0060084) |
0.1 | 1.3 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.2 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 3.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.1 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 1.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 1.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 1.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 2.1 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 1.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 1.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 1.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 1.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.8 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.7 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 1.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 2.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.0 | 0.8 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 1.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 2.4 | GO:0046545 | development of primary female sexual characteristics(GO:0046545) |
0.0 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.3 | GO:0060544 | regulation of necroptotic process(GO:0060544) negative regulation of necroptotic process(GO:0060546) |
0.0 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.3 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.6 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.8 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.2 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.7 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0071426 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.3 | GO:0008542 | visual learning(GO:0008542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 23.6 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
5.2 | 41.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
5.0 | 19.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.6 | 13.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
4.2 | 20.8 | GO:0031523 | Myb complex(GO:0031523) |
3.8 | 11.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
3.8 | 15.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.0 | 9.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
2.8 | 42.2 | GO:0042581 | specific granule(GO:0042581) |
2.5 | 25.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.2 | 24.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.7 | 6.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.7 | 23.1 | GO:0090543 | Flemming body(GO:0090543) |
1.6 | 4.8 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.4 | 21.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.3 | 3.8 | GO:1990423 | RZZ complex(GO:1990423) |
1.1 | 3.4 | GO:0042583 | chromaffin granule(GO:0042583) |
1.1 | 20.2 | GO:0005861 | troponin complex(GO:0005861) |
1.1 | 7.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.1 | 6.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.1 | 21.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.0 | 10.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 2.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.9 | 5.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.9 | 3.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.9 | 9.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 7.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.9 | 6.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 2.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
0.8 | 3.3 | GO:0000802 | transverse filament(GO:0000802) |
0.8 | 3.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 2.3 | GO:0005940 | septin ring(GO:0005940) |
0.8 | 2.3 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.8 | 3.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 10.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 2.1 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 2.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 0.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.7 | 10.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 9.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.7 | 2.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.7 | 5.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 2.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 11.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 1.8 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.6 | 3.5 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.6 | 6.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 3.3 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 9.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 3.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 16.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 9.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 6.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.5 | GO:0071920 | cleavage body(GO:0071920) |
0.5 | 2.6 | GO:0044301 | climbing fiber(GO:0044301) |
0.5 | 2.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 10.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 9.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 12.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 8.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 36.1 | GO:0005844 | polysome(GO:0005844) |
0.5 | 4.2 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 2.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 25.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 5.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 2.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 3.3 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 3.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 5.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 1.2 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.4 | 2.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 4.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 1.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 2.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 1.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 3.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 2.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 1.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 2.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 3.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 7.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 3.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 4.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 4.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 3.2 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 1.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 1.5 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 4.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.2 | GO:0090537 | CERF complex(GO:0090537) |
0.3 | 1.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 2.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.3 | 9.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 11.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 19.7 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 4.2 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 4.9 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 0.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.3 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 4.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.0 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.2 | 6.0 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 5.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 9.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 3.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.2 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 26.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 5.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 12.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.9 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 9.1 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 12.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 9.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 8.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.0 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.8 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 9.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 6.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 2.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 6.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 14.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 4.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 3.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 6.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 13.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 16.0 | GO:0031674 | I band(GO:0031674) |
0.1 | 3.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 3.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 1.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 14.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 6.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 7.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 5.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 11.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 2.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 2.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 2.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 2.8 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 3.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 4.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 5.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 10.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 3.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 3.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 3.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.0 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 1.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
4.3 | 12.8 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
3.5 | 10.6 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
3.1 | 24.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.0 | 11.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
2.7 | 13.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.6 | 15.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.5 | 9.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
2.5 | 4.9 | GO:0048030 | disaccharide binding(GO:0048030) |
2.4 | 9.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 7.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.2 | 6.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.0 | 10.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 8.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
2.0 | 8.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.0 | 11.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.9 | 9.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.8 | 5.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.7 | 17.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.6 | 16.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.6 | 17.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.6 | 9.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.6 | 10.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.5 | 4.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.5 | 4.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.5 | 14.7 | GO:0031014 | troponin T binding(GO:0031014) |
1.4 | 7.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.4 | 5.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.3 | 6.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.3 | 3.9 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
1.3 | 2.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.3 | 5.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.2 | 9.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.2 | 4.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.2 | 7.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.1 | 5.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.1 | 4.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.1 | 12.5 | GO:0050693 | LBD domain binding(GO:0050693) |
1.1 | 3.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 3.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.1 | 8.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.1 | 10.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.1 | 2.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
1.1 | 40.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 5.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 9.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.0 | 3.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.0 | 9.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.0 | 2.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.0 | 15.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.9 | 2.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.9 | 10.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.9 | 4.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.9 | 2.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.9 | 2.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 4.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.9 | 5.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 2.7 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.9 | 2.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 6.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.9 | 6.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 7.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 2.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.9 | 13.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.8 | 2.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.8 | 6.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 4.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.8 | 12.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.8 | 2.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.8 | 8.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 3.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.7 | 2.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.7 | 4.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.7 | 32.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 2.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.7 | 3.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 10.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.7 | 4.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 2.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.7 | 2.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 3.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 14.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 6.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.7 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.7 | 2.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 2.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 21.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 1.9 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.6 | 14.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 2.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 8.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 11.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 4.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.6 | 1.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.6 | 4.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 2.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.6 | 3.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.6 | 7.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 4.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 3.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 1.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.5 | 14.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 1.6 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.5 | 5.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 3.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 30.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 2.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 4.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 11.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 9.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 5.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 3.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 2.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 1.4 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.5 | 4.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 1.4 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.5 | 1.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.4 | 1.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.4 | 1.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 4.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 4.3 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 6.4 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 9.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 8.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 2.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.4 | 2.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.6 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 2.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 2.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 4.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.4 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 6.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 3.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 1.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 2.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 3.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 20.1 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 5.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 2.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 5.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 2.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 4.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 11.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 9.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 6.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 2.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.3 | 1.3 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.3 | 13.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.2 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 2.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 7.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 2.7 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.3 | 7.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 1.5 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.3 | 3.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 7.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 3.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 2.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 0.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 2.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 2.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 1.1 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.3 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 8.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 49.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.8 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.3 | 4.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 8.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 5.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 4.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 7.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 4.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 1.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 6.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 1.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.2 | 3.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 1.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.8 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 2.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 1.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 5.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 2.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 2.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 3.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 2.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.2 | 6.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.6 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 2.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 6.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 9.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 4.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 5.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 14.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 3.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 7.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 6.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 2.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 3.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 2.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0086077 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 2.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 2.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 14.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 1.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 4.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 3.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 4.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 1.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 4.2 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 1.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 2.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 1.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 4.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 6.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 4.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 8.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 5.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 20.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 18.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.0 | 1.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.9 | 1.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 7.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 11.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 1.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 9.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 6.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 15.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 24.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 7.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 18.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 14.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 18.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 7.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 7.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 17.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 23.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 4.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 4.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 15.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 28.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 15.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 3.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 15.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 8.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 1.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 12.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 2.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 3.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 2.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 7.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 5.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 10.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 4.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 3.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 4.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 5.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 35.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 4.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 3.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 6.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.0 | 37.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 7.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 11.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 20.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 10.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 12.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 7.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 9.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 12.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 6.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 3.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 25.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 13.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 6.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 12.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 12.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 25.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 13.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.5 | 9.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 7.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 18.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 21.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 18.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 6.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 10.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 7.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 7.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 9.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 2.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 8.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 9.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 7.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 6.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 10.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 2.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.3 | 6.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 8.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 4.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 12.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 21.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 3.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 6.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 5.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 5.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 10.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 9.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 4.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 9.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 13.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 12.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 4.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 7.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 5.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 1.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 6.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 1.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 22.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 6.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 5.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 4.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.7 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 3.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 6.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.4 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |